“A looming eye health crisis” – these are the words used to describe the situation many Aussies will face if adequate investment is not made over the next five years, according to the peak professional body for optometrists in Australia. Optometry Australia is calling on the nation’s major political parties to take vision problems more
Read More
Having emerged as Australia’s fastest growing allied health portfolio over the past 12 months, healthcare operator Healthia (ASX: HLA) has reported record revenue and earnings while supporting their staff with minimal roster changes despite COVID lockdowns and the absence of JobKeeper assistance. Amid ongoing lockdowns over the past six months and the Omicron outbreak, Healthia
Read More
With 13.2 million Australians suffering from long term eye problems, the rationale behind Healthia’s (ASX: HLA) $43m acquisition of The Optical Company was a logical opportunity to expand and investors have taken notice with HLA shares trading at all-time highs over the past month. While it may appeared a simple tack-on acquisition, such price movement
Read More
Healthia (ASX: HLA) shareholders have voted with their wallets firmly in favour of the allied healthcare provider’s expansion into optometry with the Company successfully raising $13.2m from an Entitlement Offer to fund their acquisition of The Optical Company (TOC). The $13.2m from shareholders forms part of the $43m acquisition to proceed, adding 41 optometry clinics
Read More
Leading allied healthcare company Healthia (ASX: HLA) is set to significantly increase their services and national footprint with the $43 million acquisition of optometry group The Optical Company and their 41 clinics. The acquisition is a horizontal expansion for Healthia which has primarily operated in the podiatry and physiotherapy sectors while also owning iOrthotics, Australia’s
Read More